Major depressive disorder (MDD) is a disabling mental health condition with significant economic burden. This study evaluated direct and indirect healthcare costs for patients MDD cost differences across severity levels. Adults (≥18 years) self-reported physician diagnosis of depression on the 2019 National Health Wellness Survey were stratified by disease using Patient Questionnaire (PHQ-9) sc...

Multiple sclerosis (MS) is a chronic disabling neurological disease affecting both physical and mental functions, resulting in impaired quality of life for patients their caregivers. Although studies Western countries have demonstrated that MS imposes considerable direct indirect costs on healthcare systems societies, empirical research China limited regarding the economic burden MS. This study...

Economic impacts of agricultural carbon sequestration involve direct costs of sequestration management adoption as well as a variety of indirect costs and benefits. The nature and significance of these impacts are discussed. Spatial and temporal heterogeneity in agriculture is identified as an influential factor. Techniques to estimate the cost of agricultural carbon sequestration are briefly r...

background: major thalassemia is an autosomal recessive disease with complications, mortality and serious pathology. today, the life expectancy of patients with major thalassemia has increased along with therapeutic advances. therefore, they need lifelong care, and caring for them would incur many costs. being aware of the patients’ costs can be effective for controlling and managing the costs ...

OBJECTIVE To determine the annual direct, indirect and total costs and predictors of costs in patients with systemic lupus erythematosus (SLE). METHODS One hundred and five patients with SLE completed questionnaires on health-care utilization and employment history. Predictors of costs were determined by multiple regression analyses using direct, indirect and total costs as outcome variables....

BACKGROUND Urothelial bladder cancer (UBC) is the ninth most common cancer worldwide. In Italy, the prevalence of the disease is approximately 10%, making it the fourth most prevalent cancer in the country. The increase in prevalence requires continuous surveillance and care, resulting in a significant burden on Italian National Health Service, making any improvement to the strategy for diagnos...